Clinical trials: sponsored by Anhui Provincial Hospital
Chemotherapy-induced Neutropenia
Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis
This trial is a multicenter, non-interventional, registered real-world clinical study. Based on available evidence and recommendations of guidelines, tumor patients with high risk of FN and eligible for all enrollment criteria…
- Trial name
- NCT03701841
- Testing
- PEG-rhG-CSF
- Where
- China
- Volunteers
- 1,000 people
- Sponsor
- Anhui Provincial Hospital
Immunotherapy
NK Cells Infusion for Advanced Malignancies
This study is designed to explore the safety and efficacy of natural killer (NK) cell infusion as treatment for patients with advanced malignant tumors after multiline therapy, and to evaluate the pharmacokinetics of NK cells in…
- Trial name
- NCT03619954
- Testing
- NK cells infusion
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Anhui Provincial Hospital
Gastric Carcinoma
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
To observe and evaluate the efficacy and safety of oxaliplatin with oapecitabine（XELOX）combined with apatinib as post-operative chemotherapy in locally advanced gastric adenocarcinoma with D2 dissection
- Trial name
- NCT03599778
- Testing
- Apatinib
- Where
- China
- Volunteers
- 52 people
- Sponsor
- Anhui Provincial Hospital
Ovarian Cancer
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients With Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
- Trial name
- NCT03547375
- Testing
- Apatinib
- Volunteers
- 69 people
- Sponsor
- Anhui Provincial Hospital
Cervical Cancer
Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
- Trial name
- NCT03546855
- Testing
- Apatinib
- Volunteers
- 69 people
- Sponsor
- Anhui Provincial Hospital
Two Different Treatment Methods
Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer
The investigators hope that after this research, two different treatment methods' curative effects for advanced gastric cancer can be assessed.
- Trial name
- NCT03334591
- Testing
- Apatinib
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Anhui Provincial Hospital
Post-ERCP Acute Pancreatitis
ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP
Endoscopic retrograde cholangiopancreatography (ERCP) has become one of the most important techniques in the treatment of bile duct stones.
- Trial name
- NCT02830984
- Testing
- EST+LBD+ENBD, EST+LBD
- Where
- China
- Volunteers
- 160 people
- Sponsor
- Anhui Provincial Hospital
Post-ERCP Acute Pancreatitis
Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) has been a well-recognized complication with significant morbidity and even mortality.
- Trial name
- NCT02839356
- Testing
- epinephrine, normal saline
- Where
- China
- Volunteers
- 670 people
- Sponsor
- Anhui Provincial Hospital
Biliary Calculi
Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction
Endoscopic bile duct stone (BDS) removal is a well-established treatment; however, the preference for basket or balloon catheters for extraction is operator-dependent It is reported that complete endoscopic treatment with a…
- Trial name
- NCT02909595
- Testing
- Balloon catheter, Basket catheter
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Anhui Provincial Hospital
Pancreatitis
Pentoxifylline for the Prevention of PEP
Between December 2016 and June 2017, 110 consecutive patients older than 18 years who are scheduled to undergo diagnostic or therapeutic ERCP at the Anhui Provincial Hospital will be recruited for the study.
- Trial name
- NCT02992678
- Testing
- Pentoxifylline
- Where
- China
- Volunteers
- 110 people
- Sponsor
- Anhui Provincial Hospital
Adenocarcinoma of Lung
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
The purpose of this study is to discuss the efficacy and safety of recombinant human endostatin(endostar) durative intravenous transfusion combined with pemetrexed plus cisplatin or carboplatin in the first-line treatment of…
- Trial name
- NCT02804646
- Testing
- recombinant human endostatin, pemetrexed plus cisplatin or carboplatin
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Anhui Provincial Hospital
Adenocarcinoma
Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction
Of the esophagogastric junction adenocarcinoma (AEG) is a 5 cm region of adenocarcinoma of the esophagus and stomach. Due to the special anatomical location, the biological behavior of esophageal cancer and gastric cancer are not…
- Trial name
- NCT02741778
- Testing
- Minimally invasive group, Open group
- Volunteers
- 120 people
- Sponsor
- Anhui Provincial Hospital